PHAS
PhaseBio Pharmaceuticals, Inc.
Set alert
52-week range unavailable
- Open
- 0.0807
- Prev close
- 0.0701
- Mkt cap
- 0
- Vol
- 8.60M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0665
- High
- 0.092
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2022
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 1.00
News
-
3 years ago benzinga.com
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results.
-
3 years ago benzinga.com
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 85 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday, 125 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
-
4 years ago benzinga.com
Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session
Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 413 companies reached new 52-week lows.
4 years ago businesswire.com
PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code
MALVERN, Pa.
4 years ago 247wallst.com
These Were The Five Best And Worst Performing Healthcare Stocks In September 2022
September was another lackluster month for the stock market, with the S&P 500 dropping by over 9%.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 361 companies set new 52-week lows.
4 years ago zacks.com
PhaseBio Pharmaceuticals (PHAS) Reports Q2 Loss, Lags Revenue Estimates
PhaseBio Pharmaceuticals (PHAS) delivered earnings and revenue surprises of -3.03% and 91.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the…
4 years ago businesswire.com
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 216 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 123 stocks made new 52-week lows.
4 years ago zacks.com
PhaseBio Pharmaceuticals (PHAS) Reports Q1 Loss, Misses Revenue Estimates
PhaseBio Pharmaceuticals (PHAS) delivered earnings and revenue surprises of 65.67% and 98%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
4 years ago businesswire.com
PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
-
4 years ago businesswire.com
PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab
4 years ago businesswire.com
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
-
4 years ago benzinga.com
53 Biggest Movers From Yesterday
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average…
4 years ago businesswire.com
PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference
4 years ago businesswire.com
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab
4 years ago businesswire.com
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
4 years ago businesswire.com
PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)---- $PHAS #Bentracimab--PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 671 companies achieved new lows for the year.
4 years ago businesswire.com
PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel…
-
4 years ago businesswire.com
PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update
MALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)---- $PHAS #TakeItToHeart--PhaseBio Pharmaceuticals Announces Bentracimab Manufacturing Update
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 95 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks
-
4 years ago benzinga.com
52 Weeks High And Low Article
On Friday, 106 companies reached new 52-week lows.
-
7 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For October 3, 2019
Benzinga's Top Upgrades, Downgrades For October 3, 2019
-
7 years ago benzinga.com
45 Stocks Moving In Tuesday's Mid-Day Session
45 Stocks Moving In Tuesday's Mid-Day Session
-
7 years ago benzinga.com
45 Stocks Moving In Tuesday's Mid-Day Session
45 Stocks Moving In Tuesday's Mid-Day Session
-
7 years ago benzinga.com
48 Stocks Moving In Wednesday's Mid-Day Session
48 Stocks Moving In Wednesday's Mid-Day Session
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018
Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018